Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-20

Clinical Trial Update: α-N-acetylgalactosaminidase Levels in Panic Disorder

View source ↗

Summary

A completed clinical trial evaluated levels of α-N-acetylgalactosaminidase in patients with panic disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Elazığ Mental Health and Diseases Hospital | Conditions: Panic Disorder | Status: COMPLETED